Ohio is developing a $3.6 million centralized coronavirus vaccine signup system. Here are the details
Updated Feb 24, 2021;
Posted Feb 24, 2021
MetroHealth pharmacist Brian Colbert prepares COVID-19 vaccines to be administered at the hospital on Dec. 16.Joshua Gunter, cleveland.com
Facebook Share
COLUMBUS, Ohio – Ohio’s $3.6 million centralized vaccine signup system, which is under development by business and government contactor Accenture, is necessary because the website created for the federal government had significant operational issues, according to Gov. Mike DeWine’s office.
The state originally planned to go with a coronavirus vaccine system developed for the Centers for Disease Control and Prevention by contractor Deloitte. However, there were concerns with it, said DeWine’s spokesman Dan Tierney.
REVEALED: Road map for our local vaccine delivery tweeddailynews.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tweeddailynews.com.au Daily Mail and Mail on Sunday newspapers.
A woman who is on a disability-support pension after multiple suicide attempts has been forced to sell her jewellery and skip meals to pay for her anti-depressants.
Leslie Rump, 61, from Port Stephens, north of Sydney, has been calculating every cost she has to outlay for the past two years, and doesn t know what she will do when her last batch of anti-depressants runs out, 7News reported.
Ms Rump is currently taking the medication Zyban for her severe clinical depression, which costs her $176 a month because it is not subsidised by the government.
Now Ms Rump has run out of jewellery to sell, and currently owes $1,300 in medical bills after two recent operations on her knee and back.
Pharmaceutical Society of Australia
PharMIbridge RCT training for pharmacists in regional Victoria
Training for regional Victorian pharmacists involved in the Bridging the Gap between Physical and Mental Illness in Community Pharmacy (PharMIbridge) Randomised Control Trial (RCT) was held in Melbourne on 8th & 9th February 2021.
The PharMIbridge RCT is a collaboration between The Pharmacy Guild of Australia, The Pharmaceutical Society of Australia, Griffith University and The University of Sydney. The RCT is funded by the Australian Government Department of Health as part of the Sixth Community Pharmacy Agreement.
Professor Amanda Wheeler, from Griffith University, who is leading the trial said “The aim of PharMIbridge training is to increase the confidence of the pharmacist in supporting consumers with severe and persistent mental illness and to increase access to the number of Mental Health Friendly Pharmacies across Australia. We know that mental wellbeing has been really imp